Pavel Varazdatovich Kakhktsyan

Pavel Varazdatovich Kakhktsyan

Auto-generated profile, based on publicly available information

Pavel Varazdatovich Kakhktsyan

Federal State Budget Institution «A.N. Bakulev National Medical Research Center of Cardiovascular Surgery» of the Ministry of Health of the Russian Federation (A.N. Bakulev NMRCVS)

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2025 in Russian Journal of Cardiology and Cardiovascular Surgery
Verified
Journal Article
Closed access
ISI.I. Skopin
I.I. Skopin
MLM.S. Latyshev
M.S. Latyshev
PKP.V. Kakhktsyan
P.V. Kakhktsyan
AVA.V. Vavilov
A.V. Vavilov
IFI.YU. Farulova
I.YU. Farulova
TAT.V. Asatryan
T.V. Asatryan
Objective. To evaluate the results of surgical treatment in patients with functional mitral regurgitation (FMR) and aortic valve disease. Material and methods. We retrospectively analyzed (median follow-up 61 months) postoperative outcomes in 108 patients with FMR >2 and aortic valve disease. Depending on mitral regurgitation (MR) mechanism, all patients were divided into type I (n=31) and type IIIb (n=77). Each type of mitral dysfunction was analyzed depending on mitral valve (MV) surgery: isolated aortic valve replacement (AVR), suture annuloplasty, remodeling annuloplasty (RA), multicomponent reconstructions with interventions on subvalvular structures. We examined patients before surgery, in early and late postoperative period. Hemodynamic parameters, complications, mortality, freedom from MR >2, effective left ventricular reverse remodeling, quality of life and mortality were studied. Results. In early postoperative period, 1 patient with MR type I died after isolated AVR. There were 2 redo surgeries after isolated AVR and suture annuloplasty. There were no differences in morbidity. Three patients with MR type IIIb died in early postoperative period (2 after isolated AVR and 1 after multicomponent reconstruction). There were no redo surgeries and differences in morbidity (p=0.24). In long-term postoperative period, there were no deaths or redo surgeries among patients with MR type I. Unsatisfactory quality of life was noted by 56% of patients without MV repair and all patients after suture repair. Better quality of life was observed after RA. There was no MR >2 after RA. Effective LV reverse remodeling was achieved in 100% of cases after RA, 74% without intervention and was absent after suture repair. Six patients with MR type IIIb died in long-term period. There were no significant between-group differences (p=0.50). There were 5 redo surgeries (the largest number after isolated AVR due to progression of MR). Unsatisfactory quality of life was detected in 28 patients (6 (60%) after suture repair and 13 (59%) after isolated AVR). MR >2 was absent in all patients after RA with reduction of interpapillary distance and resection of secondary chordae, 14% (n=3) after RA, 50% without intervention and 40% after isolated suture repair. Effective LV reverse remodeling was achieved in 89% of cases after RA with reduction of interpapillary distance, 100% after resection of secondary chordae, 95% after RA, 80% after suture repair and 68% without intervention. Conclusion. RA is advisable in patients with type I FMR ≥2 and aortic valve disease, mitral annulus ≥38 mm and LV EDV ≥200 ml for more predictable long-term results. In type IIIb mitral dysfunction, the indication for surgical intervention is MR ≥2, mitral annulus ≥40 mm, LV EDV ≥250 ml. Multicomponent MV reconstructions with interventions on subvalvular structures or MV replacement is advisable for IPD >35 mm. In case of IPD <35 mm and tethering <8 mm, RA is effective. IPD 8 mm require multicomponent reconstructions with interventions on subvalvular structures or MV replacement.

8 November 2024 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
ISI.I. Skopin
I.I. Skopin
MLM.S. Latyshev
M.S. Latyshev
PKP.V. Kakhktsyan
P.V. Kakhktsyan
ZUZ.R. Ukurova
Z.R. Ukurova
DMD.V. Murysova
D.V. Murysova
TAT.V. Asatryan
T.V. Asatryan
Objective: The study is aimed at assessing short- and long-term results of various strategies of surgical treatment in patients with ischemic mitral insufficiency. Methods: The study design was accomplished according to the PRISMA criteria in the PubMed, Google Scholar and eLibrary databases. Surgical treatment included 3 strategies: mitral valve replacement (MVR) with preservation of subvalvular structures, restrictive annuloplasty (RA) and reconstruction with intervention on subvalvular structures (RISS). The primary endpoint included all-cause death during 30 days or follow-up period, as well as rehospitalization caused by heart failure progression. The secondary endpoint was related to recurrence of mitral regurgitation > 2 degree, effective reverse left ventricular remodeling and reoperation. The discussion presents own authors’ experience based on treatment of 100 patients with type IIIb ischemic mitral regurgitation and low reconstructive potential (median follow-up 62 months). Results: The analysis involved 29 papers (n = 4,857) representing by 2 randomized controlled trials (7 %, n = 347) and 27 retrospective investigations (93 %, n = 4,424). All patients underwent coronary artery bypass grafting or stenting of the coronary arteries. All included studies were divided into 2 groups according to the compared type of surgery strategies: 1) isolated restrictive annuloplasty (RA) versus mitral valve replacement (MVR) with preservation of subvalvular structures (19 papers, n = 4,020); 2) isolated restrictive annuloplasty (RA) versus reconstruction with intervention on subvalvular structures (RISS) (10 papers, n = 751).Comparison of MVR and RA: 30-day mortality was 11.78% (164/1,392) in the MVR group vs 6.28% (150/2,389) in the RA group, p < 0.0001 (further indicators are referred to MVR and RA comparison, respectively); long-term mortality reached 28.62% (281/982) vs 25.35% (413/1,629), p = 0.067; mitral regurgitation > 2 degree manifested at the level of 3.82% (27/707) (paraprosthetic regurgitation) vs 18.91% (173/915), p < 0.0001; reoperation was performed in 6.56% (49/747) of patients vs 9.21% (63/684), p = 0.0622. Comparison of RISS and RA: 30-day mortality was 4.86% (15/307) in the RISS group vs 7.93% (28/353) in the RA group, p = 0.11 (further indicators are referred to RISS and RA comparison, respectively); long-term mortality was 12.62% (13/103) vs 15.53% (16/103), p = 0.55; mitral regurgitation > 2 degree was detected in 7.30% (17/233) of cases vs 24.19% (67/277), p < 0.01; rehospitalization was performed in 17.48% (18/103) of cases vs 28.16% (29/103), p = 0.07; reoperation was accomplished in 2.94% (4/136) of cases vs 7.41% (12/162), p = 0.09; effective reverse left ventricular remodeling was characterized by left ventricular end-diastolic dimension of –8.9%, p < 0.01 vs –2.2%, p = 0.04. Conclusion: The choice of a surgical treatment strategy in patients with ischemic mitral regurgitation should be determined by the type of mitral dysfunction. In type I, restrictive annuloplasty may be an effective technique, while in type IIIb, reconstruction with intervention on subvalvular structures or mitral valve replacement with preservation of subvalvular structures is necessary. Received 30 March 2024. Revised 5 July 2024. Accepted 1 October 2024. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: I.I. Skopin, M.S. Latyshev, P.V. KakhktsyanData collection and analysis: M.S. Latyshev, Z.R. Ukurova, Yu.I. BabukhinaStatistical analysis: M.S. Latyshev, T.V. Asatryan, D.V. MurysovaDrafting the article: I.I. Skopin, M.S. Latyshev, D.V. Murysova, P.V. KakhktsyanCritical revision of the article: I.I. Skopin, M.S. LatyshevFinal approval of the version to be published: I.I. Skopin, M.S. Latyshev, P.V. Kakhktsyan, Z.R. Ukurova, D.V. Murysova, Yu.I. Babukhina, A.V. Dremin, T.V. Asatryan

7 March 2023 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
APAlexandra Pisaryuk
Alexandra Pisaryuk
AMA. Yu. Moiseeva
A. Yu. Moiseeva
ZKZh. D. Kobalava
Zh. D. Kobalava
EDE. A. Domonova
E. A. Domonova
APA. S. Pisaruk
A. S. Pisaruk
VVV. V. Vladimirov
V. V. Vladimirov
Aim. Assessment of impact of the duration of preoperative antimicrobial therapy (AMT) on the sensitivity of microbiological examination and polymerase chain reaction (PCR) of blood/tissues of resected valves in operated patients with infective endocarditis (IE).Materials and methods. 52 operated patients with active IE were included prospectively (Duke criteria, 2015). All patients underwent microbiological examination of blood before admission to the cardiac surgery hospital, as well as parallel simultaneous microbiological examination and PCR of blood/tissues of excised valves, followed by Sanger sequencing. The duration of preoperative treatment was calculated from the first day of AMT according to IE diagnosis to the day of surgery.Results. The causative agent of IE was established in 84.6% (n=44) patients by means of complex etiological diagnosis. A significant decrease in the sensitivity of microbiological examination of venous blood was revealed when performed in the period before and after hospitalization to a surgical hospital (up 44.2% to 17.3%, p<0.05). When comparing microbiological examination of blood/tissues of resected valves and PCR of blood/tissues of resected valves, molecular biological methods demonstrated the greatest sensitivity, with a great advantage when examining the tissues of resected valves (17.3% and 19.2% vs. 38.5% and 75.0%, respectively; p0.05) vs. 75.0% (p0.05) vs 72.4% (p<0.001), respectively], and with AMT ≥ 29 days, microbiological examination of any biological material was negative in all patients, and PCR of blood/tissues of resected valves retained high sensitivity (0% and 0% vs. 34.8% and 78.3%, respectively; p<0.01).Conclusion. Long-term preoperative AMT significantly reduced the sensitivity of microbiological examination of resected valve blood/tissue in operated patients with IE, whereas PCR of resected valve blood/tissue was highly sensitive even with preoperative AMT for more than 29 days.

30 August 2024 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
TST.A. Simonyan
T.A. Simonyan
LBL.A. Bockeria
L.A. Bockeria
ISI.I. Scopin
I.I. Scopin
ITI.M. Tsiskaridze
I.M. Tsiskaridze
PKP.V. Kakhktsyan
P.V. Kakhktsyan
MIM.S. Ibragimov
M.S. Ibragimov
Introduction: Cardiac myxoma is the most common of the benign heart tumor. In the left atrium, it is typically located in the interatrial septum in the area of the fossa ovale; any other its localization is considered atypical. The consequences of surgical treatment of typical myxomas have been sufficiently examined; however, there are no data on treatment of atypically localized left atrium myxomas. Objective: The study is aimed to analyzing the results of surgical intervention upon atypically localized left atrium myxomas and assessing of pre- and postoperative risk factors for adverse hospital events as well as embolic complications. Methods: A retrospective review of the results upon surgical treatment of atypically localized left atrial myxomas (n = 52) through the period from 2008 to 2022 was performed.Results: Non-lethal in-hospital complications are revealed in 15 patients (29%). In-hospital mortality is 6% (n = 3). A comparative analysis of transthoracic echocardiography data, collected before surgical intervention and at the time of hospital discharge, demonstrated a decrease in the left ventricular end diastolic volume and in the left atrial dimensions (P < 0.001). Risk factors for non-lethal in-hospital complications are related to the chronic heart failure NYHA 3 (P < 0.01) and EuroSCORE II (P = 0.03). Risk factors for hospital mortality are associated with advanced age (P = 0.03) and EuroSCORE II (P = 0.03). Preoperative embolic complications are attributed to localization of myxoma on the posterior wall of the left atrium (P = 0.02), villous myxoma (P < 0.001), myxoma prolapse into the left ventricle cavity (P = 0.05).Conclusion: The presented results of surgical treatment of atypically localized left atrium myxomas are comparable to the data of the world literature, including hospital mortality rates (6%). Preoperative risk factors for non-lethal complications are related to chronic heart failure NYHA 3 and EuroSCORE II; for lethal complications they are associated with the age of patients over 65 years and EuroSCORE II. No significant effect of postoperative risk factors on lethal and non-lethal hospital complications was revealed. Received 3 May 2023. Revised 16 April 2024. Accepted 4 June 2024. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: T.A. Simonyan, I.I. Scopin, I.M. Tsiskaridze, P.V. KakhktsyanData collection and analysis: T.A. Simonyan, I.M. Tsiskaridze, I.Yu. Farulova, L.V. Spirin, M.S. IbragimovStatistical analysis: T.A. Simonyan, I.M. TsiskaridzeDrafting the article: T.A. Simonyan, I.M. TsiskaridzeCritical revision of the article: T.A. Simonyan, L.A. Bockeria, I.I. Scopin, I.M. Tsiskaridze, P.V. KakhktsyanFinal approval of the version to be published: T.A. Simonyan, L.A. Bockeria, I.I. Scopin, I.M. Tsiskaridze, P.V. Kakhktsyan, I.Yu. Farulova, L.V. Spirin, M.S. Ibragimov

19 March 2025 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
APAlexandra Pisaryuk
Alexandra Pisaryuk
APAlexandra Pisaryuk
Alexandra Pisaryuk
ALA. V. Lokhonina
A. V. Lokhonina
AMA. Y. Moiseeva
A. Y. Moiseeva
EDE. A. Domonova
E. A. Domonova
ZKZ. D. Kobalava
Z. D. Kobalava
   Aim. To study the cytokine profile of macrophages in valve tissues in operated patients with infective endocarditis (IE), its correlation with inflammatory markers for optimization of the assessment of IE activity.  Material and methods. There were prospectively included 25 adult patients with active IE (2015Duke criteria) and 24 patients with non-IE valvular heart disease admitted for cardiac surgery (2021-2022). Laboratory and instrumental examination was conducted, including pathogen verification, as well by means of Real-Time PCR in blood/tissues of resected valves, echocardiography, and neutrophil-to-lymphocyte ratio evaluation. Valvular tissues were analyzed for macrophage phenotypic characteristics using immunohistochemistry (IHC) and for pro- and anti-inflammatory cytokine gene expression via real-time PCR.   Results. IE patients had a high proportion of secondary IE due to degenerative heart defects (n = 10, 40.0 %) and left-sided localization of IE (n = 16, 64.0 %). IHC revealed a predominance of intact pro-inflammatory CD 86+ macrophages phenotype in patients without IE compared with patients with IE [0.054 (0.029-0.073) vs. 0.008 (0.0071-0.0096), p < 0.05]. There was no significant difference in the anti-inflammatory CD 206+ macrophages phenotype. In the group of operated patients with IE, Real-Time PCR revealed significant expression of IL-1β genes (Ме [IQR] 0.0037 [0.0005-0.0155] vs. 0.0002 [0.0001-0.0026], p < 0.05) and IL-6 (Ме [IQR] 0.0034 [0.0007-0.0167] vs. 0.0005 [0.0004-0.0038], p < 0.05) compared with patients without IE. There were no significant differences in anti-inflammatory cytokines. The level of cytokine gene expression by tissue macrophages, depending on the presence of embolic events, etiological affiliation to S. aureus, as well as hospital mortality and the combined endpoint (death from all causes or recurrence of IE in 6 months after surgery) did not differ between IE patients with or without events. IL-1β had the most favorable characteristics for assessing the activity of IE (IL-1β AUC 0.816 (p = 0.02)).   Conclusion. Increased macrophages destruction with excessive release of pro-inflammatory cytokines in the valve tissue determines the uncontrolled course of IE and the need for cardiac surgery. IL-1β has a high diagnostic value for determining the inflammation activity in operated patients with IE.

12 August 2026 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
PKPavel A. Karavaikin
Pavel A. Karavaikin
MLMikhail Sergeevich Latyshev
Mikhail Sergeevich Latyshev
VAValery Sergeevich Arakelyan
Valery Sergeevich Arakelyan
PKPavel Varazdatovich Kakhktsyan
Pavel Varazdatovich Kakhktsyan
VPVasil Georgievich Papitashvili
Vasil Georgievich Papitashvili
DKDzhumber Yakovlevich Khinchagov
Dzhumber Yakovlevich Khinchagov